Investment, Funding & Disinvestments

The hospital will roll out in four phases covering technical planning, project management, commissioning, and full operational launch under Apollo’s brand.

Sha’p Left addresses this directly by positioning its nurse-led surgeries in high-traffic, easily accessible locations such as busy taxi ranks, so that patients can receive care quickly and conveniently.

Gilead will pay USD1.68 billion upfront and commit up to USD500 million in milestone payments to secure gamgertamig (OM336), Ouro’s BCMA/CD3-targeting TCE.

The 460,000-square-foot factory will sit on a 79-acre plot within the Rowen innovation district, near Dacula, Georgia, approximately 35 miles northeast of downtown Atlanta.

This building will accommodate up to 250 researchers and provides a collaborative workspace with modular laboratories designed to support both growth and interdisciplinary exchange.

Construction is expected to be complete by the third quarter of 2027, at which point the site’s workforce is also set to double.

The companies are competing for a share of India’s Semaglutide market, which analysts estimate will reach USD1 billion over the next two years.

The new facility operates as a fully smart, digital-first outpatient center that connects appointments, consultations, diagnostics, pharmacy services, and follow-up care through integrated digital systems.

This transaction grants Collegium a second branded ADHD medication to complement its existing Jornay PM offering.

Psoriasis is a chronic autoimmune disorder in which skin cells multiply excessively, creating thick, itchy, scaly patches that affect more than 8 million Americans.